The trademark application SLISUR was filed by Nucleic Acids to the Rescue GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on June 20, 2022, and it was registered by office on September 27, 2022 without any oppositions.
It was designated 'Basic Application' for International Application 1702304 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).
A transfer of the trademark registration was recorded on May 15, 2024.
Goods And Services
The mark was filed in class 1 with following description of goods:
Chemical or biological substances and reagents for scientific purposes
Chemical or biological substances and reagents for diagnostic purposes
Chemical or biological substances and reagents for scientific or research use.
The mark was filed in class 5 with following description of goods:
Medical and veterinary preparations
Pharmaceuticals
Chemical or biological substances and reagents as part of medical and veterinary preparations
Chemical or biological substances and reagents for medical and veterinary use
Agonists for medical and veterinary use
TLR Agonists for medical and veterinary use
Agonists as part of medical and veterinary preparations
TLR Agonists as part of medical and veterinary preparations.